Table 3.
Sample characteristics at time of study enrollment.
| Full Sample (N=78) | My Guide (n=39) | My Health (n=39) | |
|---|---|---|---|
| Age; M (SD) | 52.54 (11.36) | 53.52 (11.25) | 51.55 (11.53) |
| Spanish-language preference; n (%) | 50 (64) | 25 (64) | 25 (64) |
| Born in United States; n (%) | 23 (30) | 14 (36) | 9 (23) |
| Mexican ancestry; n (%) | 50 (64) | 25 (65) | 25 (64) |
| High school education or less; n (%) | 42 (54) | 23 (59) | 19 (49) |
| Employed; n (%) | 34 (44) | 17 (44) | 17 (44) |
| Annual household income < $25,000; n (%) | 41 (53) | 23 (59) | 18 (46) |
| Married or partnered; n (%) | 50 (64) | 23 (59) | 27 (69) |
| Stage of disease; n (%) | |||
| 0 | 3 (4) | 2 (5) | 1 (3) |
| I | 28 (36) | 14 (36) | 14 (36) |
| II | 32 (41) | 16 (41) | 16 (41) |
| III | 11 (14) | 5 (13) | 6 (15) |
| Did not report | 4 (5) | 2 (5) | 2 (5) |
| Time since diagnosis (months); M (SD)* | 15.50 (7.04) | 16.18 (7.88) | 14.78 (6.07) |
| Received radiation therapy; n (%) | 55 (71) | 28 (72) | 27 (69) |
| Received chemotherapy; n (%) | 45 (58) | 19 (49) | 26 (67) |
Note.
*
Time since diagnosis was calculated as months between the date of baseline assessment and diagnosis date confirmed by medical chart review or patient-report if medical chart confirmation was not possible; M, mean; n, frequency; SD, standard deviation.